title: [Long acting analogue of somatostatin (Octreotide) for treatment of patients with neurochorioretinitis due to ocular sarcoidosis who failed corticosteroids therapy].
abstract: Neurochorioretinitis due to the course of ocular sarcoidosis is relatively rare case. It usually responds well to conventional treatment with corticosteroids. We want to present the patient effectively treated with long acting analogue of somatostatin (Octreotide), who failed to respond to previous corticosteroids treatment.
authors.affiliation: Kliniki Okulistycznej Instytutu Chirurgii Wojskowej Akademii Medycznej w Łodzi.
authors.forename: Piotr
authors.initials: P
authors.lastname: Jurowski
authors.forename: Roman
authors.initials: R
authors.lastname: Goś
authors.forename: Jolanta
authors.initials: J
authors.lastname: Kunert-Radek
mesh_terms: D002825:Chorioretinitis / Q000188:drug therapy* / Q000209:etiology*; D005128:Eye Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D009882:Ophthalmic Nerve / Q000187:drug effects; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D006728:Hormones; D015282:Octreotide